Log In
Print this Print this

Invader UGT1A1

  Manage Alerts
Collapse Summary General Information
Company Hologic Inc.
DescriptionMolecular assay to detect mutations in the UGT1A1 gene using Third Wave's Invader platform
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDetect mutations in the UGT1A1 gene to identify patients at risk of adverse reactions to Camptosar irinotecan
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today